Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,047 | 99 | 96.4% |
| Education | $76.11 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $566.51 | 29 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $253.16 | 17 | $0 (2024) |
| Indivior Inc. | $197.52 | 5 | $0 (2021) |
| Allergan Inc. | $168.25 | 7 | $0 (2019) |
| ITI, Inc. | $157.06 | 6 | $0 (2023) |
| Axsome Therapeutics, Inc. | $153.56 | 3 | $0 (2024) |
| Alkermes, Inc. | $149.77 | 9 | $0 (2024) |
| ABBVIE INC. | $129.71 | 7 | $0 (2023) |
| Orexo US, Inc. | $80.96 | 4 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $70.28 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $232.87 | 12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($70.28) |
| 2023 | $230.34 | 6 | Axsome Therapeutics, Inc. ($140.17) |
| 2022 | $493.28 | 28 | Sunovion Pharmaceuticals Inc. ($181.96) |
| 2021 | $328.08 | 18 | Sunovion Pharmaceuticals Inc. ($73.18) |
| 2020 | $243.28 | 15 | Sunovion Pharmaceuticals Inc. ($118.56) |
| 2019 | $218.29 | 10 | Allergan Inc. ($168.25) |
| 2018 | $176.44 | 5 | Indivior Inc. ($110.12) |
| 2017 | $200.05 | 7 | Sunovion Pharmaceuticals Inc. ($175.48) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ADHD | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: CNS | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: CNS | ||||||
| 06/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: CNS | ||||||
| 08/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/08/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $120.51 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/08/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: PSYCHOLOGY | ||||||
| 11/29/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: CNS | ||||||
| 11/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: CNS | ||||||
| 10/19/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 34 | $4,760 | $1,901 |
| 2022 | 1 | 24 | 45 | $6,300 | $2,818 |
| 2021 | 1 | 19 | 36 | $5,040 | $2,424 |
| 2020 | 1 | 17 | 38 | $5,320 | $2,171 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 34 | $4,760 | $1,901 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 45 | $6,300 | $2,818 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 36 | $5,040 | $2,424 | 48.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 38 | $5,320 | $2,171 | 40.8% |
About Dr. Raafea Malik, M.D
Dr. Raafea Malik, M.D is a Psychiatry healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467450239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raafea Malik, M.D has received a total of $2,123 in payments from pharmaceutical and medical device companies, with $232.87 received in 2024. These payments were reported across 101 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,047).
As a Medicare-enrolled provider, Malik has provided services to 77 Medicare beneficiaries, totaling 153 services with total Medicare billing of $9,314. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Saint Peters, MO
- Active Since 07/14/2005
- Last Updated 09/17/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1467450239
Products in Payments
- LATUDA (Drug) $546.68
- VRAYLAR (Drug) $297.96
- CAPLYTA (Drug) $227.34
- SUBLOCADE (Drug) $197.52
- REXULTI (Drug) $174.80
- Auvelity (Drug) $153.56
- ARISTADA (Drug) $119.44
- Zubsolv (Drug) $80.96
- ABILIFY MAINTENA (Drug) $78.36
- FANAPT (Drug) $52.00
- SECUADO (Drug) $34.91
- Lucemyra/Lofexidine (Drug) $28.89
- COBENFY (Drug) $27.27
- QELBREE (Drug) $21.97
- APTIOM (Drug) $19.83
- Xelstrym (Drug) $17.43
- Vivitrol 380 mg (Drug) $16.45
- Aristada 441 mg (Drug) $13.88
- INGREZZA (Drug) $13.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Peters
Satish Kulkarni, Md, MD
Psychiatry — Payments: $19,489
Dr. Chinya Murali, Md, MD
Psychiatry — Payments: $8,299
Dr. Roomana Arain, M.d, M.D
Psychiatry — Payments: $3,993
Thripura Thirtala, M.d, M.D
Psychiatry — Payments: $2,057
Srinivas Battula, Md, MD
Psychiatry — Payments: $718.20
Dawn Holemon, M.d, M.D
Psychiatry — Payments: $191.24